CHOICE: CHanges to Treatment and Outcomes in Patients With Type 2 Diabetes Initiating InjeCtablE Therapy
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
Patients initiating injectable therapy for type 2 diabetes (insulin or exenatide) in usual
clinical practice will be enrolled and followed up for two years in order to describe actual
practice with regards to the time on initial treatment regime, whether treatment regimens are
being modified, what treatment modifications are made, and clinical and patient-reported
outcomes.